Lawsuits against insurers are cropping up over consumers’ claims of being denied access to hepatitis C treatments. Over the past two weeks, multiple women have sued a health insurer due to their outright denial of the Harvoni hepatitis C treatment. Drug makers are setting restrictions before providing coverage to some hepatitis C patients, with the hope of limiting the number of patients for whom coverage is provided. Experts believe more of these types of lawsuits will be forthcoming. To read more on this issue, click here.
Last Updated on May 7, 2020 by Aimed Alliance
